ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 191 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $153,000 | +35.4% | 3,577 | +14.0% | 0.00% | 0.0% |
Q3 2019 | $113,000 | +197.4% | 3,137 | +118.6% | 0.00% | – |
Q2 2019 | $38,000 | -68.9% | 1,435 | -68.4% | 0.00% | -100.0% |
Q1 2019 | $122,000 | +74.3% | 4,547 | +3.1% | 0.00% | 0.0% |
Q4 2018 | $70,000 | -32.7% | 4,412 | -11.2% | 0.00% | 0.0% |
Q3 2018 | $104,000 | +82.5% | 4,967 | +33.8% | 0.00% | 0.0% |
Q2 2018 | $57,000 | -40.6% | 3,713 | -13.5% | 0.00% | 0.0% |
Q1 2018 | $96,000 | -30.9% | 4,291 | -6.6% | 0.00% | -50.0% |
Q4 2017 | $139,000 | +8.6% | 4,596 | +36.1% | 0.00% | 0.0% |
Q3 2017 | $128,000 | +36.2% | 3,376 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $94,000 | +42.4% | 3,376 | +76.2% | 0.00% | +100.0% |
Q1 2017 | $66,000 | +1550.0% | 1,916 | +1194.6% | 0.00% | – |
Q4 2016 | $4,000 | -84.6% | 148 | -81.4% | 0.00% | -100.0% |
Q3 2016 | $26,000 | +23.8% | 795 | +9.8% | 0.00% | 0.0% |
Q2 2016 | $21,000 | – | 724 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |